Australia markets open in 2 hours 25 minutes

Sansure Biotech Inc. (688289.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.82+0.36 (+1.76%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,202,892
1,007,119
6,450,357
4,514,539
4,762,964
Cost of revenue
297,051
286,641
2,655,368
1,279,045
969,953
Gross profit
905,840
720,478
3,794,989
3,235,494
3,793,011
Operating expenses
Research development
205,332
196,276
331,834
187,504
82,771
Selling general and administrative
509,142
426,134
829,802
434,897
558,532
Total operating expenses
815,510
668,861
1,262,150
666,900
680,876
Operating income or loss
90,330
51,617
2,532,839
2,568,594
3,112,135
Interest expense
7,507
2,409
2,091
829.4117
508.1667
Income before tax
432,374
410,478
2,315,922
2,616,205
3,070,161
Income tax expense
70,785
62,311
379,215
373,682
453,564
Income from continuing operations
361,588
348,167
1,936,707
2,242,524
2,616,597
Net income
384,733
363,721
1,936,801
2,242,696
2,616,597
Net income available to common shareholders
384,733
363,721
1,936,801
2,242,696
2,616,597
Basic EPS
1.08
0.62
3.31
3.81
4.74
Diluted EPS
1.08
0.62
3.31
3.81
4.74
Basic average shares
588,397
586,647
585,136
588,634
552,434
Diluted average shares
588,397
586,647
585,136
588,634
552,434